Skip to main content
. Author manuscript; available in PMC: 2006 Jun 2.
Published in final edited form as: Arch Ophthalmol. 2005 Nov;123(11):1570–1574. doi: 10.1001/archopht.123.11.1570

Figure 5.

Figure 5

Risk of progression to advanced age-related macular degeneration (in at least one eye in patients with both eyes at risk) based on repeated-measures logistic regression analysis of Age-Related Eye Disease Study (AREDS) participants randomized to the AREDS combined treatment group (antioxidants plus zinc [AZ]) or placebo (P), by simplified risk score assigned at baseline.